Literature DB >> 28508131

Muscle wasting in chronic kidney disease.

Eduardo A Oliveira1,2, Wai W Cheung1, Kalodiah G Toma1, Robert H Mak3.   

Abstract

Loss of lean body mass is a relevant component of the cachexia, or protein energy wasting (PEW), syndrome. Reduced muscle mass seems to be the most solid criterion for the presence of cachexia/PEW in patients with chronic kidney disease (CKD), and those with greater muscle mass loss have a higher risk of death. Children with CKD have many risk factors for lean mass and muscle wasting, including poor appetite, inflammation, growth hormone resistance, and metabolic acidosis. Mortality risks in patients with CKD increases as body mass index (BMI) and weight decreases. However, data regarding cachexia/PEW and muscle wasting in children with CKD is scarce due to lack of consensus in diagnostic criteria and an appropriate investigative methodology. Further research is urgently needed to address this important complication in the pediatric CKD setting, which may have fundamental impact on clinical outcomes.

Entities:  

Keywords:  Cachexia; Children; Chronic kidney disease; Muscle wasting; Protein energy wasting

Mesh:

Year:  2017        PMID: 28508131     DOI: 10.1007/s00467-017-3684-6

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  79 in total

1.  Diagnosis and prevalence of protein-energy wasting and its association with mortality in Japanese haemodialysis patients.

Authors:  Yoshie Kanazawa; Toshiyuki Nakao; Seizo Murai; Tomonari Okada; Hiroshi Matsumoto
Journal:  Nephrology (Carlton)       Date:  2017-07       Impact factor: 2.506

Review 2.  Exercise for children with chronic kidney disease and end-stage renal disease.

Authors:  Emma L Clapp; Alan Bevington; Alice C Smith
Journal:  Pediatr Nephrol       Date:  2011-01-14       Impact factor: 3.714

3.  Mortality prediction by surrogates of body composition: an examination of the obesity paradox in hemodialysis patients using composite ranking score analysis.

Authors:  Kamyar Kalantar-Zadeh; Elani Streja; Miklos Z Molnar; Lilia R Lukowsky; Mahesh Krishnan; Csaba P Kovesdy; Sander Greenland
Journal:  Am J Epidemiol       Date:  2012-03-16       Impact factor: 4.897

Review 4.  Inflammation and cachexia in chronic kidney disease.

Authors:  Wai W Cheung; Kyung Hoon Paik; Robert H Mak
Journal:  Pediatr Nephrol       Date:  2010-01-29       Impact factor: 3.714

5.  Volumetric bone mineral density and bone structure in childhood chronic kidney disease.

Authors:  Rachel J Wetzsteon; Heidi J Kalkwarf; Justine Shults; Babette S Zemel; Bethany J Foster; Lindsay Griffin; C Frederic Strife; Debbie L Foerster; Darlene K Jean-Pierre; Mary B Leonard
Journal:  J Bone Miner Res       Date:  2011-09       Impact factor: 6.741

6.  Relationship between nutritional status and the glomerular filtration rate: results from the MDRD study.

Authors:  J D Kopple; T Greene; W C Chumlea; D Hollinger; B J Maroni; D Merrill; L K Scherch; G Schulman; S R Wang; G S Zimmer
Journal:  Kidney Int       Date:  2000-04       Impact factor: 10.612

Review 7.  Cachexia in children with chronic kidney disease: challenges in diagnosis and treatment.

Authors:  Robert H Mak
Journal:  Curr Opin Support Palliat Care       Date:  2016-12       Impact factor: 2.302

8.  Kidney function and sarcopenia in the United States general population: NHANES III.

Authors:  Robert N Foley; Changchun Wang; Areef Ishani; Allan J Collins; Anne M Murray
Journal:  Am J Nephrol       Date:  2007-04-17       Impact factor: 3.754

Review 9.  Growth in children with chronic kidney disease: role of nutrition, growth hormone, dialysis, and steroids.

Authors:  Elizabeth G Ingulli; Robert H Mak
Journal:  Curr Opin Pediatr       Date:  2014-04       Impact factor: 2.856

10.  Resistance training to reduce the malnutrition-inflammation complex syndrome of chronic kidney disease.

Authors:  Carmen Castaneda; Patricia L Gordon; Russell C Parker; Katherine Leigh Uhlin; Ronenn Roubenoff; Andrew S Levey
Journal:  Am J Kidney Dis       Date:  2004-04       Impact factor: 8.860

View more
  13 in total

1.  Leptin and ghrelin in chronic kidney disease: their associations with protein-energy wasting.

Authors:  Nur Canpolat; Lale Sever; Ayse Agbas; Mehmet Tasdemir; Cigdem Oruc; Ozlem Balcı Ekmekci; Salim Caliskan
Journal:  Pediatr Nephrol       Date:  2018-07-06       Impact factor: 3.714

2.  Renal mass reduction increases the response to exogenous insulin independent of acid-base status or plasma insulin levels in rats.

Authors:  Elinor C Mannon; Christina L Sartain; Trevin C Wilkes; Jingping Sun; Aaron J Polichnowski; Paul M O'Connor
Journal:  Am J Physiol Renal Physiol       Date:  2021-08-16

3.  Factors associated with 1-year changes in serum fibroblast growth factor 23 levels in pediatric patients with chronic kidney disease.

Authors:  Natsumi Yamamura-Miyazaki; Toshimi Michigami; Keiichi Ozono; Katsusuke Yamamoto; Yukiko Hasuike
Journal:  Clin Exp Nephrol       Date:  2022-05-25       Impact factor: 2.617

4.  Dietary Inflammatory Potential Is Associated With Sarcopenia Among Chronic Kidney Disease Population.

Authors:  Ying Huang; Mengru Zeng; Lei Zhang; Jingzheng Shi; Yuan Yang; Fuyou Liu; Lin Sun; Li Xiao
Journal:  Front Nutr       Date:  2022-05-11

5.  Body composition and arterial stiffness in pediatric patients with chronic kidney disease.

Authors:  Vasiliki Karava; Nikoleta Printza; John Dotis; Despoina Demertzi; Christina Antza; Vasilios Kotsis; Fotios Papachristou; Stella Stabouli
Journal:  Pediatr Nephrol       Date:  2019-03-29       Impact factor: 3.714

6.  Atractylenolide III Attenuates Muscle Wasting in Chronic Kidney Disease via the Oxidative Stress-Mediated PI3K/AKT/mTOR Pathway.

Authors:  Mingqing Wang; Rong Hu; Yanjing Wang; Lingyu Liu; Haiyan You; Jiaxing Zhang; Xiaohui Wu; Tingting Pei; Fujing Wang; Lu Lu; Wei Xiao; Lianbo Wei
Journal:  Oxid Med Cell Longev       Date:  2019-04-18       Impact factor: 6.543

7.  Comparison of Performance of Equations for Estimated Glomerular Filtration Rate in Chinese Patients with Biopsy-Proven Diabetic Nephropathy.

Authors:  Yiting Wang; Junlin Zhang; Geer Teng; Yucheng Wu; Qianqian Han; Hanyu Li; Tingli Wang; Fang Liu
Journal:  Dis Markers       Date:  2019-09-15       Impact factor: 3.434

8.  Expression Levels of Long Non-Coding RNAs Change in Models of Altered Muscle Activity and Muscle Mass.

Authors:  Keisuke Hitachi; Masashi Nakatani; Shiori Funasaki; Ikumi Hijikata; Mizuki Maekawa; Masahiko Honda; Kunihiro Tsuchida
Journal:  Int J Mol Sci       Date:  2020-02-27       Impact factor: 5.923

9.  Diaphragmatic dysfunction associates with dyspnoea, fatigue, and hiccup in haemodialysis patients: a cross-sectional study.

Authors:  Bin Wang; Qing Yin; Ying-Yan Wang; Yan Tu; Yuchen Han; Min Gao; Mingming Pan; Yan Yang; Yufang Xue; Li Zhang; Liuping Zhang; Hong Liu; Rining Tang; Xiaoliang Zhang; Jingjie Xiao; Xiaonan H Wang; Bi-Cheng Liu
Journal:  Sci Rep       Date:  2019-12-18       Impact factor: 4.379

10.  High Levels of Physical Activity May Promote a Reduction in Bone Mineral Density in Peritoneal Dialysis.

Authors:  Armando Raimundo; Zelinda Charrua; Nuno Batalha; Catarina Pereira; Jose Parraca; Pablo Tomas-Carus
Journal:  Medicina (Kaunas)       Date:  2020-09-11       Impact factor: 2.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.